The elections will take place from 23 May - 5 June 2022 and is held online via the link https://icnapedia.org/ballot-2022 . All eligible voters will be sent their unique codes during the perior 23 May 2022 - 25 May 2022 . The codes are sent out in batches. Please only contact us if you have not received your unique voting code by 26 MAY 2020. Meanwhile we would strongly encourage you to go through the candidate statements , which are now available online. Any new ICNA members, including those who have been converted to FULL Membership from JUNIOR Membership after 23 May 2020 will NOT be eligible to vote in this election. The election site will be open tilll 5 June 2022 6PM CET.
Autoimmune Encephalitis beyond NMDA-R Antibodies
Josep Dalmau (SJD Barcelona Children's Hospital, Spain)
Autoimmune encephalitis is a new category of diseases in which autoantibodies against neuronal cell surface and synaptic proteins cause a wide variety of syndromes and diseases resulting in neuropsychiatric manifestations. The spectrum of diseases, comorbidities and triggers is different between adults and children and symptoms vary according to the type of autoantibody. In children the most frequent autoimmune encephalitis is anti-NMDAR followed by a few others such as anti-MOG (myelin oligodendrocyte glycoprotein), anti-GABAaR, and other. In this presentation I will review the spectrum of these diseases in children, some of the underlying pathogenic mechanisms involved, and the approaches to treatment.
- Clinically recognize anti-NMDA receptor and other autoimmune encephalitis
- Optimally manage the initial treatment approach of anti-NMDAR encephalitis
- Describe the underlying antibody-mediated pathogenic mechanisms in anti-NMDAR and other types of autoimmune encephalitis.